Moderna raises 2021 Covid-19 vaccine output forecast to at least 600 million doses

Moderna Inc said on Monday it would produce at least 600 million doses of its Covid-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine.

The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said.

Moderna said it has so far supplied about 18 million doses to the U.S. government as part of a deal for 200 million doses. It has also signed a deal with the Canadian government for 40 million doses.

Related Posts

Jaipur Jail Nursing Officer Busted for Supplying Narcotics to Inmates

Jaipur: A Grade Second nursing officer at Jaipur Central Jail has been arrested for allegedly supplying narcotic drugs to prisoners, following a tip-off from an inmate and a trail of…

17760 banned capsules caught during checking, accused arrested

Bijnor/Rehad:  Late Friday evening, a joint team of drug inspector and police seized 17760 banned capsules during checking. The police have also arrested the accused. The drug inspector and police…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Spurious cosmetic packaging factory busted in northwest Delhi

Spurious cosmetic packaging factory busted in northwest Delhi

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

UP plans US FDA-accredited medical device testing lab

UP plans US FDA-accredited medical device testing lab

Patent rejected for MNC’s cancer drug, generics to follow

Patent rejected for MNC’s cancer drug, generics to follow

Zydus brings world’s first Nivolumab biosimilar to India

Zydus brings world’s first Nivolumab biosimilar to India